Swiss All Share Index
16.669,46
PKT
+61,82
PKT
+0,37
%
Werbung
Analysen zu Swiss All Share Index-Werten
Datum | Rating | Analyst | |
---|---|---|---|
06.09.12 | Richemont neutral | J.P. Morgan Cazenove | |
06.09.12 | Swiss Re sell | Goldman Sachs Group Inc. | |
06.09.12 | Novartis neutral | Exane-BNP Paribas SA | |
06.09.12 | ABB (Asea Brown Boveri) buy | UBS AG | |
06.09.12 | UBS underperform | Cheuvreux SA | |
06.09.12 | Holcim outperform | Exane-BNP Paribas SA | |
06.09.12 | Holcim outperform | Cheuvreux SA | |
06.09.12 | Holcim hold | ING | |
05.09.12 | Swatch (I) outperform | Credit Suisse Group | |
05.09.12 | UBS overweight | J.P. Morgan Cazenove | |
05.09.12 | UBS overweight | J.P. Morgan Cazenove | |
05.09.12 | Partners Group hold | Vontobel Research | |
05.09.12 | DKSH hold | Vontobel Research | |
05.09.12 | Holcim hold | Vontobel Research | |
05.09.12 | Novartis reduce | Vontobel Research | |
05.09.12 | Swiss Re buy | Vontobel Research | |
05.09.12 | Richemont neutral | Sarasin Research | |
05.09.12 | Richemont buy | Vontobel Research | |
04.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
04.09.12 | Zurich Insurance hold | Deutsche Bank AG | |
04.09.12 | Swiss Life buy | Deutsche Bank AG | |
04.09.12 | Swiss Life buy | Nomura | |
04.09.12 | Baloise reduce | Nomura | |
04.09.12 | Richemont hold | Deutsche Bank AG | |
04.09.12 | Holcim hold | Vontobel Research | |
04.09.12 | Sika hold | Vontobel Research | |
04.09.12 | Partners Group hold | Vontobel Research | |
04.09.12 | Sika neutral | Sarasin Research | |
04.09.12 | Partners Group neutral | Sarasin Research | |
04.09.12 | UBS hold | ING | |
04.09.12 | UBS hold | ING | |
03.09.12 | Swatch (I) overweight | HSBC | |
04.09.12 | Richemont neutral | J.P. Morgan Cazenove | |
03.09.12 | UBS buy | Deutsche Bank AG | |
03.09.12 | Clariant sell | Goldman Sachs Group Inc. | |
03.09.12 | Givaudan sell | Goldman Sachs Group Inc. | |
03.09.12 | Sulzer buy | Vontobel Research | |
03.09.12 | Holcim hold | Vontobel Research | |
03.09.12 | Novartis reduce | Vontobel Research | |
03.09.12 | Novartis kaufen | Die Actien-Börse |